Kidney Cancer Treatment Options: Surgery, Ablation, Systemic Therapy, and Surveillance

Management of kidney cancer is tailored to tumor stage and patient factors:

  • Surgery: Radical nephrectomy (entire kidney) or partial/nephron-sparing nephrectomy (tumor only) for T1–T2 tumors. Laparoscopic and robotic approaches are standard.
  • Ablation: Radiofrequency ablation (RFA), cryoablation, or microwave ablation for small tumors in patients who are not surgical candidates.
  • Active surveillance: For small (<3 cm), low-grade tumors in elderly or comorbid patients—serial imaging monitors growth.
  • Systemic therapy (advanced/metastatic disease):
    • VEGF tyrosine kinase inhibitors: sunitinib, pazopanib, cabozantinib, lenvatinib.
    • mTOR inhibitors: everolimus, temsirolimus.
    • Immunotherapy: nivolumab, pembrolizumab, ipilimumab/nivolumab combination.
  • Radiation therapy: Primarily palliative for bone or brain metastases; stereotactic body radiation therapy (SBRT) for oligometastatic disease.

A multidisciplinary tumor board optimizes treatment sequencing. Clinical trials provide access to novel agents.

Kidney Disease - Related Articles